Delivery Order SPE2DB24D1021-SPE2DB25FEZDY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) with a ceiling value of $2,030.22. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,452.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,389.74 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 20 mg capsules (100-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and has an ultimate completion date of July 24, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 20 mg tablets (100-count) valued at $1,000.16, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $10,468.50 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count units). This firm fixed price, non-set-aside delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.40 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg capsules (100-count units) on July 30, 2025. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 31, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,211.15 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) under a firm fixed price contract type. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside competitive procurement. The product will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZDYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2.71K to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitive award uses firm fixed pricing with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99B global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a significant portfolio of federal contract awards with the Defense Logistics Agency covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for controlled pharmaceutical products reflects the vendor's established capability to fulfill federal medical supply requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/1/25 |